Widely read:
The Exchange has sought clarification from Natco Pharma Ltd on February 24 2026 with reference to news appeared in https://www.livemint.com dated February 24 2026 quoting "Eris Lifesciences inks deal with Natco Pharma for weight-loss drug semaglutide."
The reply is awaited.
Disclaimer: This content is for information only and should not be considered investment advice or a recommendation.
For grievances: [email protected]
Ask Value Research 
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
